FDA Approves First Prescription Digital Therapy for Major Depression, Rejoyn

THURSDAY, April 4, 2024 -- The U.S. Food and Drug Administration (FDA) has cleared the first prescription digital therapeutic authorized for the adjunctive treatment of major depressive disorder (MDD) symptoms.
The approval is for Rejoyn, a...